So far this year, Amplion has tracked 67 Seed and Series A investments into early-stage biotechs – down from 92 or a 27% decrease during the same period last year. That said, the biotech sector continues to witness rapid advancements, with numerous early-stage...
The research conducted by Pharma orgs across the globe in the field of gene therapy has brought forth significant advancements and potential benefits for patients with various genetic disorders and diseases. These pharmaceutical companies have contributed to expanding...
The emerging pharmaceutical industry plays a vital role in developing innovative treatments and therapies for various diseases. In 2023, several emerging pharmaceutical companies have made significant strides towards advancing their drug programs across a range of...
Advances in Cell Therapy in 2023: A Year of Promising Preclinical Studies Cell therapy has emerged as a groundbreaking field in medical science, offering innovative solutions for a range of diseases and conditions that were previously considered challenging to treat....
A number of emerging biopharma companies have announced significant funding rounds in recent months, as investors continue to bet on the potential of these early-stage firms to develop new therapies for a variety of diseases. Here are some of the top deals, along with...
